Britannia Life Sciences Inc(TSE:BLAB)
CA$0.07-0.01 (-7.14%)
TSE:BLAB
Britannia Life Sciences Inc financials statements
CA$0.07
At close:-0.01 (-7.14%)
Want to see TSE:BLAB full AI Analyst Report?
Britannia Life Sciences Inc (BLAB) Ratios
2 Followers
Britannia Life Sciences Inc Ratios
TSE:BLAB's free cash flow for Q1 2026 was C$-659.38K. For the 2026 fiscal year, TSE:BLAB's free cash flow was increased by C$0.00 and operating cash flow was C$-659.38K. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Mar 25 | Jun 23 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.57 | 2.72 | 0.26 | 0.92 | 0.42 |
| Quick Ratio | 6.57 | 2.72 | 0.24 | 0.92 | 0.42 |
| Cash Ratio | 0.46 | 2.15 | 0.13 | 0.57 | 0.20 |
| Solvency Ratio | 4.21 | 1.40 | -0.28 | 0.43 | -0.98 |
| Operating Cash Flow Ratio | -0.40 | -0.72 | 0.20 | 0.26 | 0.34 |
| Short-Term Operating Cash Flow Coverage | -10.01 | -20.32 | 0.99 | 0.61 | 0.57 |
| Net Current Asset Value | C$ 15.67M | C$ 4.62M | C$ -12.86M | C$ -8.27M | C$ -12.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.16 | 0.33 | 0.36 | 0.25 |
| Debt-to-Equity Ratio | 0.01 | 0.29 | 2.99 | 1.20 | 3.84 |
| Debt-to-Capital Ratio | 0.01 | 0.23 | 0.75 | 0.54 | 0.79 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.20 | 0.66 | 0.47 | 0.08 |
| Financial Leverage Ratio | 1.15 | 1.84 | 9.13 | 3.35 | 15.59 |
| Debt Service Coverage Ratio | -13.50 | -18.69 | -0.54 | 2.44 | -1.59 |
| Interest Coverage Ratio | -57.36 | -21.19 | 0.13 | 0.21 | 0.16 |
| Debt to Market Cap | 0.01 | 0.14 | 0.61 | 0.54 | 0.24 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.05 | 0.06 | 0.07 |
| Net Debt to EBITDA | 0.79 | 1.36 | -3.15 | 0.84 | -0.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.18% | 7.40% | 64.12% | 72.43% | 72.08% |
| EBIT Margin | -306.82% | -1206.25% | -29.39% | 104.81% | -150.15% |
| EBITDA Margin | -293.59% | -1189.96% | -25.05% | 108.61% | -147.55% |
| Operating Profit Margin | -306.82% | -609.28% | 2.29% | 2.78% | 5.20% |
| Pretax Profit Margin | 2860.35% | -1235.00% | -59.00% | 91.48% | -181.84% |
| Net Profit Margin | 2753.40% | 2001.95% | -62.99% | 79.39% | -211.76% |
| Continuous Operations Profit Margin | 2753.40% | -1235.00% | -80.80% | 91.45% | -191.59% |
| Net Income Per EBT | 96.26% | -162.10% | 106.76% | 86.78% | 116.45% |
| EBT Per EBIT | -932.27% | 202.70% | -2581.41% | 3295.78% | -3497.28% |
| Return on Assets (ROA) | 54.78% | 63.67% | -21.42% | 21.59% | -73.30% |
| Return on Equity (ROE) | 63.01% | 117.33% | -195.58% | 72.39% | -1142.96% |
| Return on Capital Employed (ROCE) | -6.94% | -28.27% | 1.47% | 0.94% | 2.97% |
| Return on Invested Capital (ROIC) | -6.62% | -27.58% | 1.22% | 0.84% | 2.14% |
| Return on Tangible Assets | 54.78% | 63.67% | -114.03% | 85.57% | -383.50% |
| Earnings Yield | 89.53% | 60.75% | -41.98% | 33.00% | -74.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.30 | 1.62 | 6.26 | 4.01 | 4.07 |
| Payables Turnover | 0.33 | 0.15 | 1.14 | 0.78 | 0.69 |
| Inventory Turnover | 0.00 | 0.00 | 14.73 | 0.00 | 0.00 |
| Fixed Asset Turnover | 5.98 | 2.58 | 10.49 | 14.16 | 13.37 |
| Asset Turnover | 0.02 | 0.03 | 0.34 | 0.27 | 0.35 |
| Working Capital Turnover Ratio | 0.04 | -0.49 | -1.86 | -2.46 | -1.17 |
| Cash Conversion Cycle | 116.86 | -2134.93 | -238.26 | -375.43 | -440.89 |
| Days of Sales Outstanding | 1232.19 | 225.47 | 58.30 | 91.04 | 89.62 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 24.78 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1115.33 | 2360.40 | 321.34 | 466.47 | 530.52 |
| Operating Cycle | 1232.19 | 225.47 | 83.07 | 91.04 | 89.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | 0.01 | 0.01 | 0.03 |
| Free Cash Flow Per Share | -0.01 | -0.02 | 0.01 | 0.01 | 0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -654901.50 | 6.20 | 3.55 | 32.15 |
| Capital Expenditure Coverage Ratio | 0.00 | -654901.50 | 6.20 | 3.55 | 32.15 |
| Operating Cash Flow Coverage Ratio | -5.05 | -1.41 | 0.29 | 0.14 | 0.54 |
| Operating Cash Flow to Sales Ratio | -2.44 | -7.09 | 0.28 | 0.19 | 0.38 |
| Free Cash Flow Yield | -7.92% | -21.53% | 15.44% | 5.68% | 13.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1.12 | -2.60 | -2.38 | 3.03 | -1.35 |
| Price-to-Sales (P/S) Ratio | 30.75 | 32.95 | 1.50 | 2.41 | 2.85 |
| Price-to-Book (P/B) Ratio | 0.70 | 1.93 | 4.66 | 2.19 | 15.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.63 | -4.65 | 6.47 | 17.62 | 7.67 |
| Price-to-Operating Cash Flow Ratio | -12.63 | -4.65 | 5.43 | 12.66 | 7.43 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 1.28 | 0.01 | -0.02 | -0.00 |
| Enterprise Value Multiple | -9.69 | -1.41 | -9.13 | 3.05 | -2.26 |
| Enterprise Value | 13.51M | 6.18M | 17.32M | 21.21M | 24.37M |
| EV to EBITDA | -9.69 | -1.41 | -9.13 | 3.05 | -2.26 |
| EV to Sales | 28.44 | 16.73 | 2.29 | 3.31 | 3.34 |
| EV to Free Cash Flow | -11.68 | -2.36 | 9.88 | 24.26 | 8.98 |
| EV to Operating Cash Flow | -11.68 | -2.36 | 8.28 | 17.44 | 8.70 |
| Tangible Book Value Per Share | 0.13 | 0.04 | -0.07 | -0.04 | -0.11 |
| Shareholders’ Equity Per Share | 0.13 | 0.04 | 0.02 | 0.04 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | 0.00 | 0.02 | 0.00 | -0.05 |
| Revenue Per Share | 0.00 | 0.00 | 0.05 | 0.04 | 0.07 |
| Net Income Per Share | 0.08 | 0.05 | -0.03 | 0.03 | -0.14 |
| Tax Burden | 0.96 | -1.62 | 1.07 | 0.87 | 1.16 |
| Interest Burden | -9.32 | 1.02 | 2.01 | 0.87 | 1.21 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.15 | 5.39 | 0.43 | 0.53 | 1.84 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.03 | 0.16 | 0.15 |
| Income Quality | -0.09 | 0.57 | -0.44 | 0.21 | -0.20 |
Currency in CAD

